Fundraising Fox

Henry Skinner

Investor

Chief Executive Officer at AMR Action Fund

About

Microbiologist, venture investor, and executive focused on antimicrobial drug development. Previously SVP Venture at Tekla Capital Management and Deputy Head/Managing Director of the Novartis Venture Fund, and CEO of SelectX and NeoGenesis Pharmaceuticals.

Contact· self-published, not guessed

Deals · 1

Trellis BioscienceQuoted

via AMR Action Fund · filed Jan 2026

press ↗

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at AMR Action Fund

Frequently asked questions

Who is Henry Skinner?
Microbiologist, venture investor, and executive focused on antimicrobial drug development. Previously SVP Venture at Tekla Capital Management and Deputy Head/Managing Director of the Novartis Venture Fund, and CEO of SelectX and NeoGenesis Pharmaceuticals.
Where does Henry Skinner work?
Henry Skinner is Chief Executive Officer at AMR Action Fund.